The evolution of azelaic acid

Cutis

Volumn 77, Issue 2 SUPPL., 2006, Pages 4-6

  Fleischer Jr , Alan B ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZELAIC ACID; DERMATOLOGICAL AGENT; DICARBOXYLIC ACID;

ACNE VULGARIS; HUMAN; HYPERPIGMENTATION; REVIEW; ROSACEA; SKIN DISEASE;

ACNE VULGARIS; DERMATOLOGIC AGENTS; DICARBOXYLIC ACIDS; HUMANS; HYPERPIGMENTATION; ROSACEA; SKIN DISEASES;

EID: 33645096288     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Breathnach AS, Nazzaro-Porro M, Passi S. Azelaic acid. Br J Dermatol. 1984;111:115-120.
2. Passi S, Rothschild-Boros MC, Fasella P, et al. An application of high performance liquid chromatography to analysis of lipids in archaeological samples. J Lipid Res. 1981;22:778-784.
3. Nazzaro-Porro M, Passi S. Identification of tyrosinase inhibitors in cultures of Pityrosporum. J Invest Dermatol. 1978;71:205-208.
4. Mingrone G, Greco AV, Nazzaro-Porro M. Toxicity of azelaic acid. Drugs Exp Clin Res. 1983;9:447-455.
5. Nazzaro-Porro M, Passi S. Effetto degli acidi dicarbossilici in alcune dermatosi pigmentarie. G Ital Dermatol. 1978;113:401-404.
6. Pathak MA, Ciganek ER, Wick M, et al. An evaluation of the effectiveness of azelaic acid as a depigmenting and chemotherapeutic agent. J Invest Dermatol. 1985;85:222-228.
7. Lowe NJ, Rizk D, Grimes P, et al. Azelaic acid 20% cream in the treatment of facial hyperpigmentation in darker-skinned patients. Clin Ther. 1998;20:945-959.
8. Kakita LS, Lowe NJ. Azelaic acid and glycolic acid combination therapy for facial hyperpigmentation in darker-skinned patients: a clinical comparison with hydroquinone. Clin Ther. 1998;20:960-970.
9. Breathnach AS, Martin B, Nazzaro-Porro M, et al. Effects of dicarboxylic acids on normal human melanocytes in dispersed tissue culture. Br J Dermatol. 1979;101:641-649.
10. Hu F, Mah K, Teramura DJ. Effects of dicarboxylic acids on normal and malignant melanocytes in culture. Br J Dermatol. 1986;114:17-26.
11. Passi S, Picardo M, Nazzaro-Porro M. Antimitochondrial effect of saturated medium chain length (C8-C13) dicarboxylic acids. Biochem Pharmacol 1984;33:103-108.
12. Picardo M, Passi S, Sirianni MC, et al. Activity of azelaic acid on cultures of lymphoma- and leukemia-derived cell lines, normal resting and stimulated lymphocytes and 3T3 fibroblasts. Biochem Pharmacol. 1985;34:1653-1658.
13. Nazzaro-Porro M, Passi S, Picardo M, et al. Beneficial effect of 15% azelaic acid cream on acne vulgaris. Br J Dermatol. 1983;109:45-48.
14. Nazzaro-Porro M, Passi S, Picardo M, et al. Azelaic acid in the treatment of acne [in Italian]. G Ital Dermatol Venereol. 1989;124:175-184.
15. Bojar RA, Holland KT. Azelaic acid: a review of its antimicrobial properties. Rev Contemp Pharmacother. 1993;4:403-414.
16. Mayer-da-Silva A, Gollnick H, Detmar M, et al. Effects of azelaic acid on sebaceous gland, sebum excretion rate and keratinization pattern in human skin, an in vivo and in vitro study. Acta Derm Venereol Suppl (Stockh). 1989;143:20-30.
17. Topert M, Rach P, Siegmund F. Pharmacology and toxicology of azelaic acid. Acta Derm Venereol Suppl (Stockh). 1989;143:14-19.
18. Aksakal AB, Koruyucu M, Önder M, et al. A comparative study of metronidazole 1% cream versus azelaic acid 20% cream in the treatment of acne. Gazi Med J. 1997;8:144-147.
19. Gollnick PM, Graupe K, Zaumseil RP. Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne. Eur J Dermatol. 2001;6:538-544.
20. Gollnick PM, Graupe K, Zaumseil RP. Azelaic acid 15% gel in the treatment of acne vulgaris. combined results of two double-blind clinical comparative studies [in German]. J Dtsch Dermatol Ges. 2004;2:841-847.
21. Passi S, Picardo M, De Luca C, et al. Scavenging activity of azelaic acid on hydroxyl radicals "in vitro". Free Radic Res Commun. 1991;11:329-339.
22. Passi S, Picardo M, Zompetta M, et al. The oxyradical-scavenging activity of azelaic acid in biological systems. Free Radic Res Commun. 1991;15:17-28.
23. Akamatsu H, Komura J, Asada Y, et al. Inhibitory effect of azelaic acid on neutrophil functions: a possible cause for its efficacy in treating pathogenetically unrelated diseases. Arch Dermatol Res. 1991;283:162-166.
24. Miyachi Y, Yoshioka A, Imamura S, et al. Effect of antibiotics on the generation of reactive oxygen species. J Invest Dermatol. 1986;86:449-453.
25. Miyachi Y, Imamura S, Niwa Y. Anti-oxidant action of metronidazole: a possible mechanism of action in rosacea. Br J Dermatol. 1986;114:231-234.
26. Nazzaro-Porro M, Passi S, Picardo M, et al. L'acido azelaico nella rosacea? G Ital Dermatol Venereol. 1991;126:19-27.
27. Carmichael AJ, Marks KA, Graupe KA, et al. Topical azelaic acid in the treatment of rosacea. J Dermatolog Treat. 1993;4(suppl 1):S19-S22.
28. Bjerke R, Fyrand O, Graupe K. Double-blind comparison of azelaic acid 20% cream and its vehicle in treatment of papulo-pustular rosacea. Acta Derm Venereol. 1999;79:456-459.
29. Thiboutot D, Thieroff-Ekerdt R, Graupe K. Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: results from two vehicle-controlled, randomized phase III studies. J Am Acad Dermatol. 2003;48:836-845.